---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-035584"
form_type: "8-K"
ticker: null
cik: "0001522860"
company_name: "Acutus Medical, Inc."
filed_at: "2023-10-31T23:59:59+00:00"
generated_at: "2026-06-09T04:36:42.715297+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Acutus Medical transfers to Nasdaq Capital Market; bid price compliance extended to April 2024

## Summary
- Approved transfer from Nasdaq Global Market to The Nasdaq Capital Market effective Oct 31, 2023; symbol remains "AFIB".
- Granted additional 180-day compliance period until April 29, 2024 to regain $1.00 minimum bid price.
- If non-compliant after extended period, Nasdaq may initiate delisting; Company can appeal.
- Company may consider a reverse stock split to cure the bid price deficiency.

## SEC filing metadata
- accession: 0001628280-23-035584
- form_type: 8-K
- cik: 0001522860
- company_name: Acutus Medical, Inc.
- filed_at: 2023-10-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522860/000162828023035584/0001628280-23-035584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522860/000162828023035584/afib-20231027.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-035584
- JSON: https://secwatch.observer/filing/0001628280-23-035584.json
- Plain text: https://secwatch.observer/filing/0001628280-23-035584.txt

## Key facts
- Listing & Compliance Notices
  Acutus Medical, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5810(c)(3)(A)
  source text: ymbol “AFIB”. The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Market and listed companies must meet certain financial requirements and comply with Nasdaq’s corporate governance requirements. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), if a company listed on The Nasdaq Capital Market is not deemed in compliance before the expiration of the 180-day compliance period, it will be afforded an additional 180-day compliance period, provided that on the 180th day of the first compliance period it meets the applicable marke
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000162828023035584/0001628280-23-035584-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.